Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Formation of the Platelet Plug

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...

Structure and Function of Platelets

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...

Disorders of Hemostasis

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Embracing the Multifaceted Roles of Biomolecules in Biology and Medicine.

Biomolecules·2025

Same author

Inflammation: Is It a Healer, Confounder, or a Promoter of Cardiometabolic Risks?

Biomolecules·2024

Same author

Editorial: Insights in diabetes: molecular mechanisms 2022.

Frontiers in endocrinology·2023

Same author

Coronavirus Disease and Acute Vascular Events.

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·2020

Same author

Intron-specific Single Nucleotide Polymorphisms of Fat Mass and Obesity- Associated Gene in Obese and Overweight Individuals of the Indian Adult Population- A Pilot Study.

Current diabetes reviews·2019

Same author

Antiplatelet and Anticoagulant Therapies for Prevention of Ischemic Stroke.

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·2016

Search research articles

Related Experiment Video

Updated: Jun 17, 2026

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation

Published on: May 23, 2025

Platelet hyperfunction as risk factor for chronic and acute coronary events.

Gundu H R Rao¹

¹Laboratory Medicine & Pathology, MMC 609, Medical School, University of Minnesota, Minneapolis, Minnesota, 55455.

Toxicology Mechanisms and Methods

|December 22, 2009

Summary

This summary is machine-generated.

Indians face high rates of vascular diseases like hypertension and stroke. Environmental toxicants and genetic factors may worsen these conditions by affecting blood platelets and vascular function.

More Related Videos

Microfluidics in Assessing Platelet Function

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

Analyzing Platelet Subpopulations by Multi-color Flow Cytometry

Analyzing Platelet Subpopulations by Multi-color Flow Cytometry

Published on: June 10, 2025

Related Experiment Videos

Last Updated: Jun 17, 2026

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation

Published on: May 23, 2025

Microfluidics in Assessing Platelet Function

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

Analyzing Platelet Subpopulations by Multi-color Flow Cytometry

Analyzing Platelet Subpopulations by Multi-color Flow Cytometry

Published on: June 10, 2025

Area of Science:

Cardiovascular Biology
Environmental Health
Hematology

Background:

Indian populations exhibit disproportionately high incidences of vascular complications, including hypertension, atherosclerosis, coronary artery disease (CAD), and stroke.
Existing risk factors inadequately explain the elevated vascular disease burden, suggesting potential roles for genetic predisposition and environmental toxicants.
Vascular dysfunction, characterized by arterial wall changes and altered endothelial-platelet balance, is central to the pathogenesis of these diseases.

Purpose of the Study:

To review known risk factors for CAD in the Indian population.
To explore the impact of environmental toxicants, eicosanoids, and inflammatory mediators on vascular biology.
To elucidate the role of blood platelets and their derived biomolecules in hypertension, atherogenesis, thrombosis, and stroke.

Main Methods:

Literature review of risk factors for coronary artery disease (CAD).
Analysis of the effects of environmental toxicants on vascular physiology and pathology.
Examination of platelet function and signaling pathways in vascular disease pathogenesis.

Main Results:

Elevated vascular risk factors do not fully account for the high disease burden in Indians.
Environmental toxicants and inflammatory mediators may accelerate vascular disease progression.
Platelet activation and altered signaling pathways, potentially influenced by toxicants, contribute to hypertension, atherosclerosis, and thrombosis.

Conclusions:

Vascular dysfunction, driven by factors including environmental toxicants affecting platelet function, significantly contributes to the high incidence of cardiovascular diseases in Indians.
Further research is needed to understand the specific mechanisms by which environmental toxicants impact vascular signaling and increase disease risk.
Targeting platelet pathways and mitigating environmental exposures may offer strategies to reduce the vascular disease burden in this population.